The primary test for pancreatitis is a blood draw measuring levels of digestive enzymes called lipase and amylase. A lipase or amylase level at least three times the normal upper limit, combined with characteristic abdominal pain, is usually enough to confirm acute pancreatitis without any imaging at all. This two-out-of-three diagnostic standard (pain, elevated enzymes, imaging findings) comes from the revised Atlanta classification, which is the framework most hospitals use.
But diagnosing pancreatitis is rarely just one test. Depending on whether the episode is acute or chronic, and whether doctors need to find the cause or assess severity, the testing can involve blood work, imaging, stool samples, and sometimes specialized procedures.
Blood Tests That Confirm Acute Pancreatitis
Lipase is the preferred blood test because it stays elevated longer than amylase and is more specific to the pancreas. Most emergency departments run both, and results typically come back within a few hours. If either enzyme is three or more times the upper limit of normal, pancreatitis is confirmed in the right clinical context. Lipase rises within 4 to 8 hours of symptom onset and can remain elevated for up to two weeks, while amylase peaks earlier and returns to normal faster.
Your doctor will also check a liver enzyme called ALT. This isn’t to diagnose pancreatitis itself but to figure out what caused it. An ALT level above 150 units per liter has a positive predictive value around 81 to 95 percent for gallstone pancreatitis, meaning if ALT is that high, gallstones are very likely the trigger. At levels above 300, the specificity climbs to 94 percent. This result can change your treatment plan significantly, since gallstone pancreatitis often requires gallbladder removal.
How CRP Predicts Severity
C-reactive protein, or CRP, doesn’t diagnose pancreatitis, but it helps predict how bad it will get. CRP is an inflammation marker that peaks around 48 hours after symptoms start. A level above 150 mg/dL at that point is associated with necrotizing pancreatitis (where parts of the pancreas begin to die) with a sensitivity and specificity both above 80 percent. If your CRP stays low, that’s a reassuring sign the episode is likely to be mild.
Ultrasound: Finding the Cause
An abdominal ultrasound is typically the first imaging test ordered, not to see the pancreas directly but to look for gallstones. Gallstones are the most common cause of acute pancreatitis, and ultrasound detects them with over 95 percent sensitivity under normal conditions. During an active pancreatitis episode, though, that sensitivity drops to around 67 to 78 percent because intestinal swelling and gas can obscure the view.
Ultrasound is also decent at spotting stones stuck in the common bile duct, with sensitivity between 50 and 80 percent and specificity around 95 percent. It’s less reliable for very small stones (called microlithiasis), catching only about 55 percent of them. If ultrasound comes back negative but gallstones are still suspected, doctors typically move to more advanced imaging.
CT Scans: Assessing Damage
A contrast-enhanced CT scan is the workhorse imaging test for pancreatitis, but it’s not always needed right away. If the diagnosis is clear from blood work and symptoms, CT is usually delayed until 72 to 96 hours after onset, because that’s when complications like necrosis become visible.
On a CT scan, mild pancreatitis (called interstitial edematous pancreatitis) shows an enlarged pancreas that still takes up contrast dye normally, sometimes with hazy streaking in the surrounding fat and small pockets of fluid. The key finding that separates mild from severe is whether the pancreas enhances with contrast. Areas that don’t light up indicate dead tissue, which is the hallmark of necrotizing pancreatitis.
Radiologists use a scoring system called the CT Severity Index to grade what they see. Points are assigned for inflammation (0 to 4) and necrosis (0 to 4 based on the percentage of pancreas affected). Higher scores correlate with longer hospital stays and greater risk of complications. If gas bubbles appear within a necrotic collection on CT, that raises concern for infection, which may require drainage or surgery.
MRCP: Mapping the Ducts
Magnetic resonance cholangiopancreatography, or MRCP, is a specialized MRI that produces detailed images of the pancreatic and bile ducts without any needles, dyes, or scopes. It works by making fluid in the ducts appear bright white on the scan, revealing blockages, narrowing, or stones that a regular ultrasound might miss.
MRCP is particularly useful when doctors suspect a bile duct stone is the cause but ultrasound hasn’t found it, or when they need a detailed map of duct anatomy before a procedure. Studies show MRCP is comparable to the older, more invasive technique of passing a scope into the ducts (ERCP) for identifying duct abnormalities. It correctly identifies the site of duct obstruction in roughly 84 to 91 percent of cases. Because it’s completely noninvasive, it carries no risk of triggering a new episode of pancreatitis, which is a known complication of ERCP.
Tests for Chronic Pancreatitis
Chronic pancreatitis develops over months or years of repeated inflammation and requires a different testing approach. Blood enzyme levels are often normal or only mildly elevated because the pancreas has lost so much of its functional tissue. Instead, diagnosis relies on imaging and tests of pancreatic function.
Endoscopic Ultrasound (EUS)
Endoscopic ultrasound places a tiny ultrasound probe at the tip of a flexible scope that’s passed through the mouth into the stomach and upper intestine, putting it right next to the pancreas. This closeness gives a level of detail no external imaging can match. EUS can detect subtle early signs of chronic pancreatitis that CT and MRI miss entirely, including slight lobularity of the pancreatic tissue, tiny cysts within the gland, thickening along the walls of the pancreatic duct, and dilation of small side-branch ducts.
Findings are scored using standardized criteria. If none of these features are present, chronic pancreatitis is unlikely. If five or more are found, the diagnosis is considered likely even when other tests are still normal.
Stool Elastase Test
This is a simple, noninvasive test that measures a digestive enzyme called elastase-1 in your stool. The pancreas produces elastase, so low levels indicate the gland isn’t making enough digestive enzymes, a condition called exocrine pancreatic insufficiency. A level below 200 micrograms per gram is the standard cutoff for diagnosis. Levels above 500 micrograms per gram are considered normal. Values between 200 and 500 fall into a gray zone where some degree of impaired function may be present but isn’t definitive.
Secretin Stimulation Test
This is the most sensitive functional test for chronic pancreatitis but also the most involved. A hormone called secretin is injected into your bloodstream, which should prompt the pancreas to release fluid rich in bicarbonate into the small intestine. A thin tube collects that fluid, and the bicarbonate concentration is measured. A peak bicarbonate level below 80 milliequivalents per liter is generally considered diagnostic of chronic pancreatitis. This test can catch early disease before structural changes show up on imaging, but it’s only available at specialized centers.
Which Test Comes First
In practice, testing follows a predictable sequence. If you arrive at the emergency department with severe upper abdominal pain radiating to your back, you’ll get blood drawn for lipase, amylase, liver enzymes, and basic metabolic markers. If lipase comes back elevated, you have your diagnosis. An abdominal ultrasound follows to check for gallstones. If the episode is mild and responds to treatment, you may never need a CT scan. If pain worsens, fever develops, or organ function declines, CT with contrast enters the picture to look for necrosis and complications.
For chronic symptoms like recurring pain, weight loss, oily stools, or new-onset diabetes with no clear cause, the path typically starts with a CT or MRCP, moves to endoscopic ultrasound if those are inconclusive, and may include stool elastase or a secretin stimulation test to measure how well the pancreas still functions.